- Home
- / Elekta
Elekta
Stock Price
KR66.7
2024-10-29
Market Capitalization
KR25.5 B
2024-10-29
Revenue
KR18.1 B
FY, 2024
Elekta Summary
Company Summary
- Overview
- Elekta is a medical device company that manufactures radiotherapy solutions for cancer care and brain disorders. It offers solutions in both radiotherapy treatment and oncology informatics systems for oncology clinics.
- Type
- Public
- Status
- Active
- Founded
- 1972
- HQ
- Stockholm, SE | view all locations
- Website
- http://elekta.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Gustaf Salford, President and CEO
Steve Wort, COO
Karin Svenske, Executive Vice President, Human Resources
Operating MetricsView all
Order Intake
kr18B
FY, 2022
Engineers
650
FY, 2022
Patents
1.8K
FY, 2022
LocationsView all
25 locations detected
Stockholm, Stockholms län HQ
Sweden
Kungstensgatan 18, Box 7593
Atlanta, GA
United States
400 Perimeter Center Terrace #50
North Sydney, NSW
Australia
Suite 10.2, Level 10/146 Arthur St
Innsbruck, Tirol
Austria
Klostergasse 4
Zaventem, Vlaams Gewest
Belgium
Belgicastraat 11
São Paulo, SP
Brazil
Av. Brg. Faria Lima, 1355 - 20 andar - Jardim Paulistano
Elekta Financials
Summary Financials
- Revenue (Q3, 2025)
- kr4.7B
- Gross profit (Q3, 2025)
- kr2.1B
- Net income (Q3, 2025)
- kr336.0M
- Cash (Q3, 2025)
- kr3.6B
- EBIT (Q3, 2025)
- kr511.0M
- Enterprise value
- $30.8B